212 related articles for article (PubMed ID: 22609133)
21. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
Yamagishi S; Nakamura K; Inoue H
Med Hypotheses; 2005; 65(6):1013-5. PubMed ID: 16146671
[TBL] [Abstract][Full Text] [Related]
22. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
Yamagishi S; Matsui T; Takenaka K; Nakamura K; Takeuchi M; Inoue H
Diabetes Metab Res Rev; 2009 Mar; 25(3):266-71. PubMed ID: 19165765
[TBL] [Abstract][Full Text] [Related]
23. Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications.
Ceriello A
Diabetes Nutr Metab; 1999 Feb; 12(1):42-6. PubMed ID: 10517306
[TBL] [Abstract][Full Text] [Related]
24. Advanced glycation end products: sparking the development of diabetic vascular injury.
Goldin A; Beckman JA; Schmidt AM; Creager MA
Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase.
Shen GX
Can J Physiol Pharmacol; 2010 Mar; 88(3):241-8. PubMed ID: 20393589
[TBL] [Abstract][Full Text] [Related]
26. [The role of glucose and reactive oxygen species in the development of vascular complications of diabetes mellitus].
Ksiazek K; Wiśniewska J
Przegl Lek; 2001; 58(10):915-8. PubMed ID: 11957818
[TBL] [Abstract][Full Text] [Related]
27. AGE, RAGE, and ROS in diabetic nephropathy.
Tan AL; Forbes JM; Cooper ME
Semin Nephrol; 2007 Mar; 27(2):130-43. PubMed ID: 17418682
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress: a key contributor to diabetic cardiomyopathy.
Khullar M; Al-Shudiefat AA; Ludke A; Binepal G; Singal PK
Can J Physiol Pharmacol; 2010 Mar; 88(3):233-40. PubMed ID: 20393588
[TBL] [Abstract][Full Text] [Related]
29. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
Rolo AP; Palmeira CM
Toxicol Appl Pharmacol; 2006 Apr; 212(2):167-78. PubMed ID: 16490224
[TBL] [Abstract][Full Text] [Related]
30. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.
Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R
Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075
[TBL] [Abstract][Full Text] [Related]
31. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.
Fiorentino TV; Prioletta A; Zuo P; Folli F
Curr Pharm Des; 2013; 19(32):5695-703. PubMed ID: 23448484
[TBL] [Abstract][Full Text] [Related]
32. Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications.
Papachristoforou E; Lambadiari V; Maratou E; Makrilakis K
J Diabetes Res; 2020; 2020():7489795. PubMed ID: 33123598
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology of peripheral arterial disease in diabetes mellitus.
Yang SL; Zhu LY; Han R; Sun LL; Li JX; Dou JT
J Diabetes; 2017 Feb; 9(2):133-140. PubMed ID: 27556728
[TBL] [Abstract][Full Text] [Related]
34. Metabolic memory - the implications for diabetic complications.
Otto-Buczkowska E; Machnica L
Endokrynol Pol; 2010; 61(6):700-3. PubMed ID: 21104645
[TBL] [Abstract][Full Text] [Related]
35. The cellular and molecular mechanisms of diabetic complications.
King GL; Brownlee M
Endocrinol Metab Clin North Am; 1996 Jun; 25(2):255-70. PubMed ID: 8799700
[TBL] [Abstract][Full Text] [Related]
36. Diabetes and the impairment of reproductive function: possible role of mitochondria and reactive oxygen species.
Amaral S; Oliveira PJ; Ramalho-Santos J
Curr Diabetes Rev; 2008 Feb; 4(1):46-54. PubMed ID: 18220695
[TBL] [Abstract][Full Text] [Related]
37. Carbonyl stress and diabetic complications.
Miyata T; Ishikawa N; van Ypersele de Strihou C
Clin Chem Lab Med; 2003 Sep; 41(9):1150-8. PubMed ID: 14598864
[TBL] [Abstract][Full Text] [Related]
38. Diabetes and antioxidants: myth or reality?
Haidara MA; Yassin HZ; Zakula Z; Mikhailidis DP; Isenovic ER
Curr Vasc Pharmacol; 2010 Sep; 8(5):661-72. PubMed ID: 19485907
[TBL] [Abstract][Full Text] [Related]
39. Review of diabetes: identification of markers for early detection, glycemic control, and monitoring clinical complications.
Wu JT
J Clin Lab Anal; 1993; 7(5):293-300. PubMed ID: 8410489
[TBL] [Abstract][Full Text] [Related]
40. Metabolic memory: mechanisms and implications for diabetic vasculopathies.
Zhang E; Wu Y
Sci China Life Sci; 2014 Aug; 57(8):845-51. PubMed ID: 25104458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
